ArriVent Biopharma Stock
ArriVent develops pharmaceutical products to cure presently untreatable cancer.
Sign up today and learn more about ArriVent Biopharma Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About ArriVent Biopharma Stock
ArriVent is a biopharmaceutical company developing pharmaceutical products to cure presently untreatable cancer.
SVP, Development Operations & Business Systems
CMO and Co-Founder
Chairman, Co-founder and Chief Executive Officer
Chief Business OfficerChief Business Officer
CEO and Chairman of Board of Directors